1 апр. 2022 г. · The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. Vol 145, No 18 · Correction to · Doi: 10.

Guideline-directed medical therapy (GDMT) for heart failure. (HF) with reduced ejection fraction (HFrEF) now includes 4 medication classes which include sodium- ...

The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.

For patients with HF, execution of advance care directives can be useful to improve documentation of treatment preference, delivery of patient-centered care, ...

Sacubitril/valsartan is 1 of the “4 pillars” of medical care for HFrEF. The 2022 AHA/ACC/HFSA HF guideline recommends sacubitril/valsartan as a Class I, Level ...

This page contains the guidelines for the management of heart failure (HF) jointly created and published by the American College of Cardiology.

The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.

1 апр. 2022 г. · Management of comorbid conditions in patients with HF may be beneficial. The new guideline provides recommendations for select patients with HF ...

1 апр. 2022 г. · New ACC/AHA/HFSA guideline redefines heart failure stages to focus on prevention, updates treatment options and emphasizes care coordination.

25 авг. 2023 г. · The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence.